-
-
7 . Periodical
Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial
- 저자
- by Dandona, Paresh; Mathieu, Chantal; Phillip, Moshe; Hansen, Lars; Griffen, Steven C, et al.
- 소스
- The Lancet Diabetes & Endocrinology; November 2017, Vol. 5 Issue: 11 p864-876, 13p